Cynata Partners with the University of Western Australia to Boost Stem Cell Therapy for Lung Fibrosis
Idiopathic Pulmonary Fibrosis, News
On February 3, 2015, Australian stem cell and regenerative medicine company Cynata Therapeutics Ltd announced delivery testing of mesenchymal stem cells (MSCs) as a lung fibrosis treatment, addressing a market believed ... Read more